Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS – Get Free Report) insider Jeffrey Farrow sold 2,111 shares of the business’s stock in a transaction on Tuesday, March 17th. The stock was sold at an average price of $69.42, for a total value of $146,545.62. Following the sale, the insider owned 47,635 shares of the company’s stock, valued at […]

Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS – Get Free Report) insider Elizabeth Yeu Lin sold 375 shares of the stock in a transaction on Tuesday, March 17th. The shares were sold at an average price of $69.42, for a total value of $26,032.50. Following the completion of the transaction, the insider directly owned 24,077 shares of the […]

Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS – Get Free Report) insider Dianne Whitfield sold 4,174 shares of the business’s stock in a transaction that occurred on Thursday, March 19th. The stock was sold at an average price of $67.00, for a total transaction of $279,658.00. Following the completion of the sale, the insider owned 35,028 shares in […]

Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS – Get Free Report) General Counsel Bryan Wahl sold 4,084 shares of the company’s stock in a transaction on Tuesday, March 17th. The stock was sold at an average price of $69.42, for a total value of $283,511.28. Following the sale, the general counsel owned 72,315 shares of the company’s stock, […]

Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN – Get Free Report) VP Padmanabh Bhatt sold 50,000 shares of the stock in a transaction that occurred on Monday, March 16th. The stock was sold at an average price of $50.28, for a total value of $2,514,000.00. Following the completion of the transaction, the vice president directly owned 17,044 shares […]